Hyperglycaemia, diabetes and risk of fragility fractures: observational and Mendelian randomisation studies

[1] Janghorbani M(2007)Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture Am J Epidemiol 166 495-505

[2] Van Dam RM(2019)Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis BMJ Open 9 e024067-220

[3] Willett WC(2022)Bone fragility in diabetes: novel concepts and clinical implications Lancet Diabetes Endocrinol 10 207-314

[4] Hu FB(2018)Insulin resistance and bone: a biological partnership Acta Diabetol 55 305-865

[5] Wang H(2017)Bone disease in diabetes: another manifestation of microvascular disease? Lancet Diabetes Endocrinol 5 827-3329

[6] Ba Y(2002)Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies J Clin Endocrinol Metab 87 3324-1208

[7] Xing Q(2018)From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment Cardiovasc Res 114 1192-1163

[8] Du J-L(2008)Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 1133-2365

[9] Hofbauer LC(2012)Nonfasting glucose, ischemic heart disease, and myocardial infarction J Am Coll Cardiol 59 2356-1005

[10] Busse B(2012)Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways Nat Genet 44 991-802

[1] Janghorbani M(2007)Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture Am J Epidemiol 166 495-505

[2] Van Dam RM(2019)Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis BMJ Open 9 e024067-220

[3] Willett WC(2022)Bone fragility in diabetes: novel concepts and clinical implications Lancet Diabetes Endocrinol 10 207-314

[4] Hu FB(2018)Insulin resistance and bone: a biological partnership Acta Diabetol 55 305-865

[5] Wang H(2017)Bone disease in diabetes: another manifestation of microvascular disease? Lancet Diabetes Endocrinol 5 827-3329

[6] Ba Y(2002)Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies J Clin Endocrinol Metab 87 3324-1208

[7] Xing Q(2018)From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment Cardiovasc Res 114 1192-1163

[8] Du J-L(2008)Mendelian randomization: using genes as instruments for making causal inferences in epidemiology Stat Med 27 1133-2365

[9] Hofbauer LC(2012)Nonfasting glucose, ischemic heart disease, and myocardial infarction J Am Coll Cardiol 59 2356-1005

[10] Busse B(2012)Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways Nat Genet 44 991-802